INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,172 | +76.7% | 2,383,039 | +47.7% | 0.10% | +87.3% |
| Q2 2023 | $34,047 | +22.6% | 1,613,596 | -0.9% | 0.06% | +14.6% |
| Q1 2023 | $27,767 | +13.3% | 1,628,518 | +32.7% | 0.05% | -2.0% |
| Q4 2022 | $24,518 | -99.9% | 1,227,100 | -2.3% | 0.05% | -10.9% |
| Q3 2022 | $27,064,000 | +7.9% | 1,256,457 | -1.2% | 0.06% | +17.0% |
| Q2 2022 | $25,076,000 | -16.5% | 1,271,622 | -0.5% | 0.05% | +17.5% |
| Q1 2022 | $30,035,000 | -15.3% | 1,278,093 | -1.9% | 0.04% | -7.0% |
| Q4 2021 | $35,480,000 | +4.3% | 1,302,510 | +5.5% | 0.04% | +2.4% |
| Q3 2021 | $34,003,000 | +54.1% | 1,234,661 | +59.3% | 0.04% | +55.6% |
| Q2 2021 | $22,064,000 | -18.1% | 775,250 | -2.0% | 0.03% | -22.9% |
| Q1 2021 | $26,939,000 | +1.9% | 790,932 | -0.4% | 0.04% | 0.0% |
| Q4 2020 | $26,437,000 | – | 794,147 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |